ConductScience.org, home

Paper42289752

Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer.

Nakao K and 7 others. Breast Cancer Res, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer. Papers, record 42289752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42289752

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Highly CD81-expressing stromal cells characterize a tumor-suppressive immune microenvironment in invasive breast cancer.
PubMed
Journal
Breast Cancer Res
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-11-02
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakao KKenju
2Komura MMasayuki
3Inaguma SShingo
4Nagano AAya
5Kato HHiroyuki
6Naiki-Ito AAya
7Toyama TTatsuya
8Takahashi SSatoru

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Tumor MicroenvironmentMajor topic
Breast NeoplasmsMajor topic
Stromal CellsMajor topic
Tetraspanin 28Major topic
Humans
Female
Prognosis
Middle Aged
Cancer-Associated Fibroblasts
Aged
Biomarkers, Tumor
Membrane Glycoproteins
Adult
Podoplanin
Neoplasm Invasiveness
Immunohistochemistry

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
23K06427Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135120598Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy.Cancer Cell2022https://conductscience.org/library/papers/35120598PubMed
238158643Single-cell RNA sequencing to explore cancer-associated fibroblasts heterogeneity: "Single" vision for "heterogeneous" environment.Cell Prolif2024https://conductscience.org/library/papers/38158643PubMed
325071162Fibroblast heterogeneity in the cancer wound.J Exp Med2014https://conductscience.org/library/papers/25071162PubMed
431197017Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts.Cancer Discov2019https://conductscience.org/library/papers/31197017PubMed
540724542Evaluation of Immunophenotypic Characteristics and Quantitative Differences of Telocytes Between Invasive Breast Cancer Subtypes.Life (Basel)2025https://conductscience.org/library/papers/40724542PubMed
632573845Heterogeneity of cancer-associated fibroblasts: Opportunities for precision medicine.Cancer Sci2020https://conductscience.org/library/papers/32573845PubMed
735020885Does CCL19 act as a double-edged sword in cancer development?Clin Exp Immunol2022https://conductscience.org/library/papers/35020885PubMed
836941633The versatile roles of testrapanins in cancer from intracellular signaling to cell-cell communication: cell membrane proteins without ligands.Cell Biosci2023https://conductscience.org/library/papers/36941633PubMed
936917949Activated fibroblasts in cancer: Perspectives and challenges.Cancer Cell2023https://conductscience.org/library/papers/36917949PubMed
1035883004Cancer-associated fibroblasts in the single-cell era.Nat Cancer2022https://conductscience.org/library/papers/35883004PubMed
1123162750High endothelial venules (HEVs) in human melanoma lesions: Major gateways for tumor-infiltrating lymphocytes.Oncoimmunology2012https://conductscience.org/library/papers/23162750PubMed
1226329536Tetraspanin CD81 promotes tumor growth and metastasis by modulating the functions of T regulatory and myeloid-derived suppressor cells.Cancer Res2015https://conductscience.org/library/papers/26329536PubMed
1339723208Prognostic value of tertiary lymphoid structures in triple-negative breast cancer: integrated analysis with the tumor microenvironment and clinicopathological features.Front Immunol2024https://conductscience.org/library/papers/39723208PubMed
1437061568Telocytes and ezrin expression in normal-appearing tissues adjacent to urothelial bladder carcinoma as predictors of invasiveness and recurrence.Sci Rep2023https://conductscience.org/library/papers/37061568PubMed
1536585155CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells.Anticancer Res2023https://conductscience.org/library/papers/36585155PubMed
1630514914Spatially and functionally distinct subclasses of breast cancer-associated fibroblasts revealed by single cell RNA sequencing.Nat Commun2018https://conductscience.org/library/papers/30514914PubMed
1737401015High endothelial venule is a prognostic immune-related biomarker in patients with resected intrahepatic cholangiocarcinoma.Cell Prolif2023https://conductscience.org/library/papers/37401015PubMed
1830117494
Increased Expression of CD81 in Breast Cancer Tissue is Associated with Reduced Patient Prognosis and Increased Cell Migration and Proliferation in MDA-MB-231 and MDA-MB-435S Human Breast Cancer Cell Lines In Vitro.
Med Sci Monit2018https://conductscience.org/library/papers/30117494PubMed
1939566495Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer.Cell2025https://conductscience.org/library/papers/39566495PubMed
2024733393The tetraspanin CD81 protein increases melanoma cell motility by up-regulating metalloproteinase MT1-MMP expression through the pro-oncogenic Akt-dependent Sp1 activation signaling pathways.J Biol Chem2014https://conductscience.org/library/papers/24733393PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42698831Cyclin-dependent kinase 4 and 6 inhibitors and the breast cancer immune ecosystem: immune remodeling, resistance, and therapeutic reprogramming.Front Immunol2026https://conductscience.org/library/papers/42698831

Source PubMed

Download CSV of cited by

Genes7

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42289752

GET https://conductscience.org/api/papers/v1/42289752/references?page=2